Loading…
AAALAC-accreditedUSDA-licensedOLAW-assuredPreclinical research & animal resources for global programs +1 (843) 589-5190 info@alphagenesisinc.com
Research animal retirement and lifetime care, now available through Alpha Genesis. Professionally managed lifetime care for retired research primates, with expert social reintroduction into stable outdoor groups led by veterinary staff deeply experienced in laboratory-animal medicine.
Learn moreStrategic investment plus the scientific expertise, research infrastructure and development support of Alpha Genesis.
Initial commitment
in research services and strategic investments through AGI Ventures.
Deployed selectively to companies chosen through AGI Ventures.
What we bring
They need to know which experiment to run next, and how to run it. AGI Ventures works alongside Alpha Genesis scientists from strategy through execution.
Structures that reduce the cash needed to reach key preclinical milestones.
Experienced scientists help find the questions that matter, and how to answer them.
Development questions become well-designed studies, run through Alpha Genesis.
The sequence of experiments from proof-of-concept to IND-enabling.
The data your next raise or partnership needs, plus relevant introductions.
Begin in rodents, advance through NHP and IND-enabling work.
The science we back
From first proof-of-concept through nonhuman primate and IND-enabling work, the questions that decide a program are biological. AGI Ventures backs the science and generates the data that answers them.
How it works
You do not need a finished protocol. Bring the science and the problem. If it is a fit, we build the study around it.
Send us a non-confidential overview of the company, technology and development goals.
Our team reviews the science, development opportunity and questions the company needs to answer.
We work together on study design, model selection, endpoints and the data package needed for the next milestone.
For selected programs, AGI Ventures develops an investment and research structure appropriate for the opportunity.
Alpha Genesis conducts the work and works with the company through data generation and interpretation.
Where appropriate, we continue with follow-on studies, financing or partnering preparation, NHP research and IND-enabling development.
Structures
No single deal structure. We develop terms around the company, the study and the opportunity.
Selection
We back companies where focused preclinical work can create a real inflection point.
We are particularly interested in opportunities where one or several well-designed experiments can materially change what a company is able to do next.
AGI Ventures companies have direct access to Alpha Genesis research infrastructure.
Commitment
Alpha Genesis has committed an initial $50 million in research services and strategic investments to companies selected through AGI Ventures.
It reflects the value of research capacity and investment support deployed through the platform, and is expected to grow as the portfolio develops.
From the founder
The companies we want to work with do not necessarily need another CRO. They need someone who can understand the science, help determine what experiment will actually move the company forward, and then help them get it done. If we believe strongly enough in the program, we are willing to invest alongside them.
If you are developing a promising biotechnology program and believe the right preclinical data could materially advance the company, we want to hear from you.
Legal notice
Participation in AGI Ventures is subject to scientific, commercial and legal review and does not constitute a commitment by Alpha Genesis or AGI Ventures to provide financing or research services. Investment and research terms are negotiated separately for each selected company. Nothing on this website constitutes an offer to purchase or sell securities.
